Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Dickson

Showing results (281-290 of 332) with videos related to

Pageof 34
Sort By:
Bioorganic & Medicinal Chemistry Letters|September 11, 2001
Synthesis and evaluation of the sunflower derived trypsin inhibitor as a potent inhibitor of the type II transmembrane serine protease, matriptaseY Q Long, S L Lee, C Y Lin, et al.
Journal of Medicinal Chemistry|November 8, 2007
Design and synthesis of novel and potent inhibitors of the type II transmembrane serine protease, matriptase, based upon the sunflower trypsin inhibitor-1Peng Li, Sheng Jiang, Sheau-Ling Lee, et al.
Glycobiology|February 9, 2006
Co-expression of matriptase and N-acetylglucosaminyltransferase V in thyroid cancer tissues--its possible role in prolonged stability in vivo by aberrant glycosylationYasuhiro Ito, Ayumi Akinaga, Kanako Yamanaka, et al.
Organic Letters|December 29, 2006
Design and synthesis of redox stable analogues of sunflower trypsin inhibitors (SFTI-1) on solid support, potent inhibitors of matriptaseSheng Jiang, Peng Li, Sheau-Ling Lee, et al.
Breast Cancer Research and Treatment|December 1, 2001
Increased stromal expression of murine urokinase plasminogen activator in a human breast cancer xenograft model following treatment with the matrix metalloprotease inhibitor, batimastatC Holst-Hansen, J A Low, R W Stephens, et al.
Cancer Research|November 15, 1989
Production of and responsiveness to transforming growth factor-beta in normal and oncogene-transformed human mammary epithelial cellsE M Valverius, D Walker-Jones, S E Bates, et al.
Journal of Steroid Biochemistry|January 1, 1986
Autocrine and paracrine growth regulation of human breast cancerM E Lippman, R B Dickson, A Kasid, et al.
The Journal of Biological Chemistry|February 5, 1992
A heparin-binding growth factor secreted from breast cancer cells homologous to a developmentally regulated cytokineA Wellstein, W J Fang, A Khatri, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1989
Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivoR Clarke, N Brünner, B S Katzenellenbogen, et al.
Cancer Cells (Cold Spring Harbor, N.Y. : 1989)|November 1, 1989
Endocrine therapy of human breast cancer cells: the role of secreted polypeptide growth factorsN Brünner, G Zugmaier, M Bano, et al.
Pageof 34

Showing results (281-290 of 332) with videos related to

Sort By:
Pageof 34
Bioorganic & Medicinal Chemistry Letters|September 11, 2001
Synthesis and evaluation of the sunflower derived trypsin inhibitor as a potent inhibitor of the type II transmembrane serine protease, matriptaseY Q Long, S L Lee, C Y Lin, et al.
Journal of Medicinal Chemistry|November 8, 2007
Design and synthesis of novel and potent inhibitors of the type II transmembrane serine protease, matriptase, based upon the sunflower trypsin inhibitor-1Peng Li, Sheng Jiang, Sheau-Ling Lee, et al.
Glycobiology|February 9, 2006
Co-expression of matriptase and N-acetylglucosaminyltransferase V in thyroid cancer tissues--its possible role in prolonged stability in vivo by aberrant glycosylationYasuhiro Ito, Ayumi Akinaga, Kanako Yamanaka, et al.
Organic Letters|December 29, 2006
Design and synthesis of redox stable analogues of sunflower trypsin inhibitors (SFTI-1) on solid support, potent inhibitors of matriptaseSheng Jiang, Peng Li, Sheau-Ling Lee, et al.
Breast Cancer Research and Treatment|December 1, 2001
Increased stromal expression of murine urokinase plasminogen activator in a human breast cancer xenograft model following treatment with the matrix metalloprotease inhibitor, batimastatC Holst-Hansen, J A Low, R W Stephens, et al.
Cancer Research|November 15, 1989
Production of and responsiveness to transforming growth factor-beta in normal and oncogene-transformed human mammary epithelial cellsE M Valverius, D Walker-Jones, S E Bates, et al.
Journal of Steroid Biochemistry|January 1, 1986
Autocrine and paracrine growth regulation of human breast cancerM E Lippman, R B Dickson, A Kasid, et al.
The Journal of Biological Chemistry|February 5, 1992
A heparin-binding growth factor secreted from breast cancer cells homologous to a developmentally regulated cytokineA Wellstein, W J Fang, A Khatri, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1989
Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivoR Clarke, N Brünner, B S Katzenellenbogen, et al.
Cancer Cells (Cold Spring Harbor, N.Y. : 1989)|November 1, 1989
Endocrine therapy of human breast cancer cells: the role of secreted polypeptide growth factorsN Brünner, G Zugmaier, M Bano, et al.
Pageof 34